2,910
Views
105
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer

, , , , , & show all
Pages 63-70 | Received 07 Mar 2007, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Kimberley Mulder, Sophie Brand, Lou Boves & Mirjam Ernestus. (2024) Processing reduced speech in the L1 and L2: a combined eye-tracking and ERP study. Language, Cognition and Neuroscience 39:5, pages 527-551.
Read now
Elisabeth Beyersmann & Jonathan Grainger. (2024) A replication of morphological flanker effects in French. Language, Cognition and Neuroscience 39:5, pages 686-691.
Read now
Roberto Ivo Da Rocha Lima Filho. (2022) Estimating the production function for the Brazilian industrial sector: A Bayesian panel VAR approach. Cogent Business & Management 9:1.
Read now
Rohit K Srivastava & Pratibha Singh. (2020) Stem Cell Therapies as a Therapeutic Option to Counter Chemo Brain: A Negative Effect of Cancer Treatment. Regenerative Medicine 15:6, pages 1789-1800.
Read now
Michelle Lycke, Tessa Lefebvre, Lies Pottel, Hans Pottel, Lore Ketelaars, Karin Stellamans, Koen Van Eygen, Philippe Vergauwe, Patrick Werbrouck, Laurence Goethals, Patricia Schofield, Tom Boterberg & Philip R. Debruyne. (2017) The distress thermometer predicts subjective, but not objective, cognitive complaints six months after treatment initiation in cancer patients. Journal of Psychosocial Oncology 35:6, pages 741-757.
Read now
Ali Tafazoli. (2017) Coenzyme Q10 in breast cancer care. Future Oncology 13:11, pages 1035-1041.
Read now
Lun Li, Dongdong Han, Xiaowei Wang, Quan Wang, Jinhui Tian, Jia Yao, Liqin Yuan, Ke Qian, Qiongyan Zou, Wenjun Yi, Enxiang Zhou & Kehu Yang. (2017) Prognostic values of Ki-67 in neoadjuvant setting for breast cancer: a systematic review and meta-analysis. Future Oncology 13:11, pages 1021-1034.
Read now
Michelle C. Janelsins, Shelli R. Kesler, Tim A. Ahles & Gary R. Morrow. (2014) Prevalence, mechanisms, and management of cancer-related cognitive impairment. International Review of Psychiatry 26:1, pages 102-113.
Read now
Olav Dahl & Marianne Brydøy. (2012) Testicular germ cell tumours – still many challenges. Acta Oncologica 51:2, pages 147-150.
Read now
Johanna Skoogh, Gunnar Steineck, Ulrika Stierner, Eva Cavallin-Ståhl, Ulrica Wilderäng, Anders Wallin, Margaret Gatz & Boo Johansson. (2012) Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3–26 years after treatment. Acta Oncologica 51:2, pages 185-197.
Read now
Mausam Singhera, Kathryn Lees, Robert Huddart & Alan Horwich. (2012) Minimizing toxicity in early-stage testicular cancer treatment. Expert Review of Anticancer Therapy 12:2, pages 185-193.
Read now
Karin Gehring, Jan Anne Roukema & Margriet M Sitskoorn. (2012) Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Review of Anticancer Therapy 12:2, pages 255-269.
Read now
Karin Gehring, Neil K Aaronson, Martin J Taphoorn & Margriet M Sitskoorn. (2010) Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Review of Anticancer Therapy 10:11, pages 1779-1795.
Read now

Articles from other publishers (92)

Kimberly Demos-Davies, Jessica Lawrence & Davis Seelig. (2024) Cancer related cognitive impairment: a downside of cancer treatment. Frontiers in Oncology 14.
Crossref
Ingrid G Boelhouwer & Tinka van Vuuren. (2024) The association of fatigue and cognitive complaints with work-related outcomes and cancer-related anxiety among employees 2–10 years after cancer diagnosis. Journal of Health Psychology.
Crossref
Meghan E. McGrady, Victoria W. Willard, AnnaLynn M. Williams & Tara M. Brinkman. (2024) Psychological Outcomes in Adolescent and Young Adult Cancer Survivors. Journal of Clinical Oncology 42:6, pages 707-716.
Crossref
AA Rogge, MA Petersen, NK Aaronson, T Conroy, L Dirven, F Fischer, EJJ Habets, JC Reijneveld, M Rose, C Sleurs, M Taphoorn, KA Tomaszewski, H Vachon, T Young & M Groenvold. (2023) Development and psychometric evaluation of item banks for memory and attention – supplements to the EORTC CAT Core instrument. Health and Quality of Life Outcomes 21:1.
Crossref
Sjoukje Lubberts & Jourik A. Gietema. (2023) Langetermijneffecten van de behandeling van patiënten met testiskanker: implicaties voor nazorg en follow-upLong-term effects of testicular cancer treatment and implications for follow-up. Tijdschrift voor Urologie 13:6-7, pages 153-161.
Crossref
Bojana Milutinovic, Rajasekaran Mahalingam, Mayela Mendt, Luis Arroyo, Alexandre Seua, Shruti Dharmaraj, Elizabeth Shpall & Cobi J. Heijnen. (2023) Intranasally Administered MSC-Derived Extracellular Vesicles Reverse Cisplatin-Induced Cognitive Impairment. International Journal of Molecular Sciences 24:14, pages 11862.
Crossref
Victoria A. Sanchez, Megan M. Shuey, Paul C. DinhJrJr, Patrick O. Monahan, Sophie D. Fosså, Howard D. Sesso, M. Eileen Dolan, Lawrence H. Einhorn, David J. Vaughn, Neil E. Martin, Darren R. Feldman, Kurt Kroenke, Chunkit Fung, Robert D. Frisina & Lois B. Travis. (2023) Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy. Journal of Clinical Oncology 41:12, pages 2211-2226.
Crossref
Kazuya Saita, Satoru Amano, Fumiko Kaneko & Hitoshi Okamura. (2023) A scoping review of cognitive assessment tools and domains for chemotherapy-induced cognitive impairments in cancer survivors. Frontiers in Human Neuroscience 17.
Crossref
Mai F. Tolba, Nada K. Sedky, Marwa A. Ali & Maha R.A. Abdollah. 2023. Handbook of Animal Models in Neurological Disorders. Handbook of Animal Models in Neurological Disorders 403 417 .
Xiaowei Han, Ming Li, Zhao Qing, Pin Lv, Renyuan Liu, Xue Liang, Qian Chen, Jiaming Lu, Wenqian Chen, Ningyu Dong, Yimin Ma, Lu Chen, Jiangong Zhang, Xiaoyan Xin, Xin Zhang & Bing Zhang. (2022) Neuroimaging advances in chemotherapy-related cognitive impairment: from clinical to preclinical research. Chinese Journal of Academic Radiology 5:3, pages 151-180.
Crossref
Simone Oerlemans, Sanne B. Schagen, Corina J. van den Hurk, Olga Husson, Dounya Schoormans & Lonneke V. van de Poll-Franse. (2021) Self-perceived cognitive functioning and quality of life among cancer survivors: results from the PROFILES registry. Journal of Cancer Survivorship 16:2, pages 303-313.
Crossref
Halina Was, Agata Borkowska, Ana Bagues, Longlong Tu, Julia Y. H. Liu, Zengbing Lu, John A. Rudd, Kulmira Nurgali & Raquel Abalo. (2022) Mechanisms of Chemotherapy-Induced Neurotoxicity. Frontiers in Pharmacology 13.
Crossref
Cecilie R. Buskbjerg, Robert Zachariae, Mads Agerbæk, Claus H. Gravholt, Lene Haldbo-Classen, S. M. Hadi Hosseini & Ali Amidi. (2021) Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients. Brain Imaging and Behavior 16:1, pages 199-210.
Crossref
Ana Dias-Carvalho, Mariana Ferreira, Rita Ferreira, Maria de Lourdes Bastos, Susana Isabel Sá, João Paulo Capela, Félix Carvalho & Vera Marisa Costa. (2021) Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events. Archives of Toxicology 96:1, pages 11-78.
Crossref
Zuzana Országhová, Michal Mego & Michal Chovanec. (2021) Long-Term Cognitive Dysfunction in Cancer Survivors. Frontiers in Molecular Biosciences 8.
Crossref
Jeena John, Manas Kinra, Jayesh Mudgal, G. L. Viswanatha & K. Nandakumar. (2021) Animal models of chemotherapy-induced cognitive decline in preclinical drug development. Psychopharmacology 238:11, pages 3025-3053.
Crossref
Sjoukje Lubberts, Coby Meijer, Marco Demaria & Jourik A. Gietema. (2020) Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act. Critical Reviews in Oncology/Hematology 151, pages 102963.
Crossref
Hayley S. Whitford, Pawel Kalinowski, Adrian Schembri, Peter Grimison, Martin Stockler, Andrew Martin, Guy C. Toner, Ian D. Davis, Paul Maruff & Ian N. Olver. (2019) The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Supportive Care in Cancer 28:7, pages 3081-3091.
Crossref
Andrée‐Anne Leclerc, Sarah Lippé, Laurence Bertout, Pascale Chapados, Aubrée Boulet‐Craig, Simon Drouin, Maja Krajinovic, Caroline Laverdière, Bruno Michon, Philippe Robaey, Émélie Rondeau, Daniel Sinnett & Serge Sultan. (2020) Inconsistencies between measures of cognitive dysfunction in childhood acute lymphoblastic leukemia survivors: Description and understanding. Psycho-Oncology 29:7, pages 1201-1208.
Crossref
Neife Aparecida Guinaim dos Santos, Rafaela Scalco Ferreira & Antonio Cardozo dos Santos. (2020) Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food and Chemical Toxicology 136, pages 111079.
Crossref
Farnaz Khadivi, Shahnaz Razavi & Fatemeh Hashemi. (2020) Protective effects of zinc on rat sperm chromatin integrity involvement: DNA methylation, DNA fragmentation, ubiquitination and protamination after bleomycin etoposide and cis-platin treatment. Theriogenology 142, pages 177-183.
Crossref
Chunkit FungPaul C. Dinh, Sophie D. FossaLois B. Travis. (2019) Testicular Cancer Survivorship. Journal of the National Comprehensive Cancer Network 17:12, pages 1557-1568.
Crossref
Chelsea Nicol, Tamara Ownsworth, Lee Cubis, William Nguyen, Matthew Foote & Mark B. Pinkham. (2019) Subjective cognitive functioning and associations with psychological distress in adult brain tumour survivors. Journal of Cancer Survivorship 13:5, pages 653-662.
Crossref
Yesol Yang, Sharron Rushton, Amanda Woodward & Cristina Hendrix. (2019) Understanding on the association between informal caregiver characteristics and cognitive function of adults with cancer: a scoping review protocol. BMJ Open 9:9, pages e031842.
Crossref
Fulvia Di Iulio, Luca Cravello, Jacob Shofany, Stefano Paolucci, Carlo Caltagirone & Giovanni Morone. (2019) Neuropsychological disorders in non-central nervous system cancer: a review of objective cognitive impairment, depression, and related rehabilitation options. Neurological Sciences 40:9, pages 1759-1774.
Crossref
Giuseppe Schepisi, Silvia De Padova, Delia De Lisi, Chiara Casadei, Elena Meggiolaro, Federica Ruffilli, Giovanni Rosti, Cristian Lolli, Giorgia Ravaglia, Vincenza Conteduca, Alberto Farolfi, Luigi Grassi & Ugo De Giorgi. (2019) Psychosocial Issues in Long-Term Survivors of Testicular Cancer. Frontiers in Endocrinology 10.
Crossref
Jennifer A. Soon, Angelyn Anton, Javier Torres, Ruth Lawrence, Phillip Parente, Joseph McKendrick, Ian D. Davis & Carmel Pezaro. (2018) Exploring the spectrum of late effects following radical orchidectomy for stage I testicular seminoma: a systematic review of the literature. Supportive Care in Cancer 27:2, pages 373-382.
Crossref
Osamu Shibayama, Kazuhiro Yoshiuchi, Masatoshi Inagaki, Yutaka Matsuoka, Eisho Yoshikawa, Yuriko Sugawara, Tatsuo Akechi, Noriaki Wada, Shigeru Imoto, Koji Murakami, Asao Ogawa & Yosuke Uchitomi. (2018) Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy. International Journal of Clinical Oncology 24:1, pages 68-77.
Crossref
Paula Jacobs, Dominic Anello & Seth Elkin-Frankston. 2019. Advances in Human Factors and Ergonomics in Healthcare and Medical Devices. Advances in Human Factors and Ergonomics in Healthcare and Medical Devices 3 14 .
XiaoJiao Huo, Teresa M. Reyes, Cobi J. Heijnen & Annemieke Kavelaars. (2018) Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice. Scientific Reports 8:1.
Crossref
Jeanne S. MandelblattBrent J. SmallGheorghe LutaArti HurriaHeather JimBrenna C. McDonaldDeena GrahamXingtao ZhouJonathan ClappWanting ZhaiElizabeth BreenJudith E. CarrollNeelima DenduluriAsma DilawariMartine ExtermannClaudine IsaacsPaul B. JacobsenLindsay C. KobayashiKelly Holohan NudelmanJames RootRobert A. SternDanielle TometichRaymond TurnerJohn W. VanMeterAndrew J. SaykinTim Ahles. (2018) Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study. Journal of Clinical Oncology 36:32, pages 3211-3222.
Crossref
Gabriel S. Chiu, Nabila Boukelmoune, Angie C.A. Chiang, Bo Peng, Vikram Rao, Charles Kingsley, Ho-Ling Liu, Annemieke Kavelaars, Shelli R. Kesler & Cobi J. Heijnen. (2018) Nasal administration of mesenchymal stem cells restores cisplatin-induced cognitive impairment and brain damage in mice. Oncotarget 9:85, pages 35581-35597.
Crossref
Myrle M. Stouten-KempermanMichiel B. de RuiterWillem BoogerdJ. Martijn KerstClemens KirschbaumLiesbeth RenemanSanne B. Schagen. (2018) Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer. Brain Connectivity 8:7, pages 398-406.
Crossref
Gordon Winocur, Ian Johnston & Hélène Castel. (2018) Chemotherapy and cognition: International cognition and cancer task force recommendations for harmonising preclinical research. Cancer Treatment Reviews 69, pages 72-83.
Crossref
Rebecca A. Harrison & Jeffrey S. Wefel. (2018) Neurocognitive Function in Adult Cancer Patients. Neurologic Clinics 36:3, pages 653-674.
Crossref
Victoria J. Bray, Haryana M. Dhillon & Janette L. Vardy. (2018) Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship 12:4, pages 537-559.
Crossref
Dong Wook Shin, Juhee Cho, Debra L. Roter, So Young Kim, Jong Hyock Park, Hyung Kook Yang, Hyun Woo Lee, Sun-Seog Kweon, Yune Sik Kang & Keeho Park. (2018) Patient’s Cognitive Function and Attitudes towards Family Involvement in Cancer Treatment Decision Making: A Patient-Family Caregiver Dyadic Analysis. Cancer Research and Treatment 50:3, pages 681-690.
Crossref
Juliana E. Bajic, Ian N. Johnston, Gordon S. Howarth & Mark R. Hutchinson. (2018) From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Frontiers in Behavioral Neuroscience 12.
Crossref
Tim A. AhlesJames C. Root. (2018) Cognitive Effects of Cancer and Cancer Treatments. Annual Review of Clinical Psychology 14:1, pages 425-451.
Crossref
Michal Chovanec, Lucia Vasilkova, Lucia Setteyova, Jana Obertova, Patrik Palacka, Katarina Rejlekova, Zuzana Sycova-Mila, Katarina Kalavska, Daniela Svetlovska, Silvia Cingelova, Beata Mladosievicova, Jozef Mardiak & Michal Mego. (2018) Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors. The Oncologist 23:5, pages 617-623.
Crossref
Sara J. HardyKevin R. KrullJeffrey S. WefelMichelle Janelsins. (2018) Cognitive Changes in Cancer Survivors. American Society of Clinical Oncology Educational Book:38, pages 795-806.
Crossref
Allan “Ben” Smith, Claudia Rutherford, Phyllis Butow, Ian Olver, Tim Luckett, Peter Grimison, Guy Toner, Martin Stockler & Madeleine King. (2018) A systematic review of quantitative observational studies investigating psychological distress in testicular cancer survivors. Psycho-Oncology 27:4, pages 1129-1137.
Crossref
Emily Tonorezos, Shrujal S. Baxi, Victoria Blinder, Darren R. Feldman, Danielle Novetsky Friedman, Matthew Matasar, Talya Salz, Armin Shahrokni & Kevin C. Oeffinger. 2018. The American Cancer Society's Principles of Oncology. The American Cancer Society's Principles of Oncology 419 436 .
Chunkit Fung, Paul Dinh, Shirin Ardeshir-Rouhani-Fard, Kerry Schaffer, Sophie D. Fossa & Lois B. Travis. (2018) Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors. Advances in Urology 2018, pages 1-20.
Crossref
Brenna C McDonald. (2017) Editorial: Cognitive and Neuroimaging Effects of Chemotherapy: Evidence Across Cancer Types and Treatment Regimens. JNCI: Journal of the National Cancer Institute 109:12.
Crossref
Milena Vitali, Carla Ida Ripamonti, Fausto Roila, Claudia Proto, Diego Signorelli, Martina Imbimbo, Giulia Corrao, Angela Brissa, Gallucci Rosaria, Filippo de Braud, Marina Chiara Garassino & Giuseppe Lo Russo. (2017) Cognitive impairment and chemotherapy: a brief overview. Critical Reviews in Oncology/Hematology 118, pages 7-14.
Crossref
Kristin J. Redmond, Russell K. Hales, Heather Anderson-Keightly, Xian C. Zhou, Megan Kummerlowe, Haris I. Sair, Mario Duhon, Lawrence Kleinberg, Gary L. Rosner & Tracy Vannorsdall. (2017) Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics 98:3, pages 603-611.
Crossref
Ali Amidi, Mads Agerbæk, Lisa M. Wu, Anders D. Pedersen, Mimi Mehlsen, Cecilie R. Clausen, Ditte Demontis, Anders D. Børglum, Anja Harbøll & Robert Zachariae. (2016) Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging and Behavior 11:3, pages 769-783.
Crossref
Anne-Katrin Hickmann, Marlene Hechtner, Minou Nadji-Ohl, Mareile Janko, Ann Katrin Reuter, Karoline Kohlmann, Markus Haug, Sonja Gr?ninger, Monika Deininger, Oliver Ganslandt, Jochem K?nig, Christian Rainer Wirtz, Jan Coburger & Mirjam Renovanz. (2016) Evaluating patients for psychosocial distress and supportive care needs based on health-related quality of life in primary brain tumors: a prospective multicenter analysis of patients with gliomas in an outpatient setting. Journal of Neuro-Oncology 131:1, pages 135-151.
Crossref
Richard Wagland, Alison Richardson, Sean Ewings, Jo Armes, Elaine Lennan, Matthew Hankins & Peter Griffiths. (2016) Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey. Supportive Care in Cancer 24:12, pages 4901-4911.
Crossref
Pok-Ja Oh & Ji Kim. (2016) The Effects of Nonpharmacologic Interventions on Cognitive Function in Patients With Cancer: A Meta-Analysis. Oncology Nursing Forum 43:5, pages E205-E217.
Crossref
Annalynn M. Williams, Clive S. Zent & Michelle C. Janelsins. (2016) What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. British Journal of Haematology 174:6, pages 835-846.
Crossref
Marco Ghezzi, Massimiliano Berretta, Alberto Bottacin, Pierfrancesco Palego, Barbara Sartini, Ilaria Cosci, Livio Finos, Riccardo Selice, Carlo Foresta & Andrea Garolla. (2016) Impact of Bep or Carboplatin Chemotherapy on Testicular Function and Sperm Nucleus of Subjects with Testicular Germ Cell Tumor. Frontiers in Pharmacology 7.
Crossref
Karin Oechsle, Michael Hartmann, Anja Mehnert, Christoph Oing, Carsten Bokemeyer & Sigrun Vehling. (2015) Symptom burden in long-term germ cell tumor survivors. Supportive Care in Cancer 24:5, pages 2243-2250.
Crossref
A. M. Williams, M. C. Janelsins & E. van Wijngaarden. (2015) Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey. Supportive Care in Cancer 24:5, pages 2155-2162.
Crossref
Wenjun Zhou, Annemieke Kavelaars & Cobi J. Heijnen. (2016) Metformin Prevents Cisplatin-Induced Cognitive Impairment and Brain Damage in Mice. PLOS ONE 11:3, pages e0151890.
Crossref
Thomas Durand, Sophie Jacob, Laura Lebouil, Hassen Douzane, Philippe Lestaevel, Amithys Rahimian, Dimitri Psimaras, Lo?c Feuvret, Delphine Leclercq, Bruno Brochet, Radia Tamarat, Fabien Milliat, Marc Benderitter, Nicolas Vayatis, Georges No?l, Kh? Hoang-Xuan, Jean-Yves Delattre, Damien Ricard & Marie-Odile Bernier. (2015) EpiBrainRad: an epidemiologic study of the neurotoxicity induced by radiotherapy in high grade glioma patients. BMC Neurology 15:1.
Crossref
Myrle M. Stouten‐Kemperman, Michiel B. de Ruiter, Matthan W.A. Caan, Willem Boogerd, Martijn J. Kerst, Liesbeth Reneman & Sanne B. Schagen. (2015) Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping 36:11, pages 4638-4647.
Crossref
Ali Amidi, Lisa M. Wu, Anders Degn Pedersen, Mimi Mehlsen, Christina Gundgaard Pedersen, Philip Rossen, Mads Agerbæk & Robert Zachariae. (2015) Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment. Supportive Care in Cancer 23:10, pages 2973-2979.
Crossref
R. Wagland, A. Richardson, J. Armes, M. Hankins, E. Lennan & P. Griffiths. (2015) Treatment-related problems experienced by cancer patients undergoing chemotherapy: a scoping review. European Journal of Cancer Care 24:5, pages 605-617.
Crossref
Joanna E. Fardell, Janette Vardy, Lauren A. Monds & Ian N. Johnston. (2015) The long-term impact of oxaliplatin chemotherapy on rodent cognition and peripheral neuropathy. Behavioural Brain Research 291, pages 80-88.
Crossref
Ali Amidi, Lisa M. Wu, Mads Agerbaek, Patrick Londin Larsen, Anders D. Pedersen, Mimi Mehlsen, Lars Larsen & Robert Zachariae. (2015) Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients. Psycho-Oncology 24:9, pages 1174-1180.
Crossref
Chunkit Fung, Sophie D. Fossa, Annalynn Williams & Lois B. Travis. (2015) Long-term Morbidity of Testicular Cancer Treatment. Urologic Clinics of North America 42:3, pages 393-408.
Crossref
Gino In & Tanya Dorff. (2015) Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors. Urologic Clinics of North America 42:3, pages 347-357.
Crossref
Karin Gehring, Martin J.B. Taphoorn, Margriet M. Sitskoorn & Neil K. Aaronson. (2015) Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma. Neuro-Oncology Practice 2:1, pages 20-31.
Crossref
Stacy A. Eisenberg, Keiko Kurita, Megan Taylor‐Ford, David B. Agus, Mitchell E. Gross & Beth E. Meyerowitz. (2014) Intolerance of uncertainty, cognitive complaints, and cancer‐related distress in prostate cancer survivors. Psycho-Oncology 24:2, pages 228-235.
Crossref
Jin-Shei Lai, Lynne I. Wagner, Paul B. Jacobsen & David Cella. (2014) Self-reported cognitive concerns and abilities: two sides of one coin?. Psycho-Oncology 23:10, pages 1133-1141.
Crossref
Jeffrey S. Wefel, Damon J. Vidrine, Salma K. Marani, Richard J. Swartz, Tracy L. Veramonti, Christina A. Meyers, Harald J. Hoekstra, Josette E. H. M. Hoekstra‐Weebers & Ellen R. Gritz. (2013) A prospective study of cognitive function in men with non‐seminomatous germ cell tumors. Psycho-Oncology 23:6, pages 626-633.
Crossref
Osamu Shibayama, Kazuhiro Yoshiuchi, Masatoshi Inagaki, Yutaka Matsuoka, Eisho Yoshikawa, Yuriko Sugawara, Tatsuo Akechi, Noriaki Wada, Shigeru Imoto, Koji Murakami, Asao Ogawa, Akira Akabayashi & Yosuke Uchitomi. (2014) Association between adjuvant regional radiotherapy and cognitive function in breast cancer patients treated with conservation therapy. Cancer Medicine 3:3, pages 702-709.
Crossref
Adrienne L. Andres, Xing Gong, Kaijun Di & Daniela A. Bota. (2014) Low-doses of cisplatin injure hippocampal synapses: A mechanism for ?chemo? brain?. Experimental Neurology 255, pages 137-144.
Crossref
Jochen Kaiser, Christoph Bledowski & Jörg Dietrich. (2014) Neural correlates of chemotherapy-related cognitive impairment. Cortex 54, pages 33-50.
Crossref
Kristy D. Hodgson, Amanda D. Hutchinson, Carlene J. Wilson & Ted Nettelbeck. (2013) A meta-analysis of the effects of chemotherapy on cognition in patients with cancer. Cancer Treatment Reviews 39:3, pages 297-304.
Crossref
Johan Le Fel, Aurélie Daireaux, Sandrine Vandenbosshe, Natacha Heutte, Olivier Rigal, Katia Rovira, Florence Joly & Vincent Roy. (2013) Impact des traitements en cancérologie sur les fonctions cognitives : le point de vue des patients, leur attente et leur souhait de participer à des ateliers de rééducation cognitive. Bulletin du Cancer 100:3, pages 223-229.
Crossref
Amanda D. Hutchinson, Jessica R. Hosking, Ganessan Kichenadasse, Julie K. Mattiske & Carlene Wilson. (2012) Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews 38:7, pages 926-934.
Crossref
Hege S. HaugnesGeorge J. BoslHink BoerJourik A. GietemaMarianne BrydøyJan OldenburgAlv A. DahlRoy M. BremnesSophie D. Fosså. (2012) Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up. Journal of Clinical Oncology 30:30, pages 3752-3763.
Crossref
Tim A. AhlesJames C. RootElizabeth L. Ryan. (2012) Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science. Journal of Clinical Oncology 30:30, pages 3675-3686.
Crossref
Heather S.L. JimKristin M. PhillipsSari ChaitLeigh Anne FaulMihaela A. PopaYun-Hsiang LeeMallory G. HussinPaul B. JacobsenBrent J. Small. (2012) Meta-Analysis of Cognitive Functioning in Breast Cancer Survivors Previously Treated With Standard-Dose Chemotherapy. Journal of Clinical Oncology 30:29, pages 3578-3587.
Crossref
Robert Abouassaly, Sophie D. Fossa, Aleksander Giwercman, Christian Kollmannsberger, Robert J. Motzer, Hans-Joachim Schmoll & Cora N. Sternberg. (2011) Sequelae of Treatment in Long-term Survivors of Testis Cancer. European Urology 60:3, pages 516-526.
Crossref
Tone Skaali, Sophie D. Fosså & Alv A. Dahl. (2011) A Prospective Study of Cognitive Complaints in Patients With Testicular Cancer. Clinical Genitourinary Cancer 9:1, pages 6-13.
Crossref
T. Skaali, S.D. Fosså, S. Andersson, M. Cvancarova, C.W. Langberg, G. Lehne & A.A. Dahl. (2011) A prospective study of neuropsychological functioning in testicular cancer patients. Annals of Oncology 22:5, pages 1062-1070.
Crossref
Tone Skaali, Sophie D. Fosså, Stein Andersson, Milada Cvancarova, Carl W. Langberg, Gustav Lehne & Alv A. Dahl. (2011) Self-reported cognitive problems in testicular cancer patients: Relation to neuropsychological performance, fatigue, and psychological distress. Journal of Psychosomatic Research 70:5, pages 403-410.
Crossref
Robert Zachariae & Mimi Yung Mehlsen. (2011) Is chemotherapy associated with cognitive impairment?. Nature Reviews Urology 8:4, pages 182-183.
Crossref
Chunkit Fung & David J. Vaughn. (2011) Complications associated with chemotherapy in testicular cancer management. Nature Reviews Urology 8:4, pages 213-222.
Crossref
Tone Skaali, Sophie D. Fosså, Stein Andersson, Carl W. Langberg, Gustav Lehne & Alv A. Dahl. (2011) Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?. Psycho-Oncology 20:4, pages 369-377.
Crossref
Andreas A. Argyriou, Konstantinos Assimakopoulos, Gregoris Iconomou, Fotini Giannakopoulou & Haralabos P. Kalofonos. (2011) Either Called “Chemobrain” or “Chemofog,” the Long-Term Chemotherapy-Induced Cognitive Decline in Cancer Survivors Is Real. Journal of Pain and Symptom Management 41:1, pages 126-139.
Crossref
Jeffrey S. Wefel, Damon J. Vidrine, Tracy L. Veramonti, Christina A. Meyers, Salma K. Marani, Harald J. Hoekstra, Josette E. H. M. Hoekstra‐Weebers, Lokesh Shahani & Ellen R. Gritz. (2010) Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 117:1, pages 190-196.
Crossref
Kerstin Hermelink, Helmut Küchenhoff, Michael Untch, Ingo Bauerfeind, Michael Patrick Lux, Markus Bühner, Juliane Manitz, Veronika Fensterer & Karin Münzel. (2010) Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study. Psycho-Oncology 19:12, pages 1321-1328.
Crossref
L. B. Travis, C. Beard, J. M. Allan, A. A. Dahl, D. R. Feldman, J. Oldenburg, G. Daugaard, J. L. Kelly, M. E. Dolan, R. Hannigan, L. S. Constine, K. C. Oeffinger, P. Okunieff, G. Armstrong, D. Wiljer, R. C. Miller, J. A. Gietema, F. E. van Leeuwen, J. P. Williams, C. R. Nichols, L. H. Einhorn & S. D. Fossa. (2010) Testicular Cancer Survivorship: Research Strategies and Recommendations. JNCI Journal of the National Cancer Institute 102:15, pages 1114-1130.
Crossref
Marco Ronald Hassler, Katarzyna Elandt, Matthias Preusser, Johann Lehrner, Petra Binder, Karin Dieckmann, Andrea Rottenfusser & Christine Marosi. (2009) Neurocognitive training in patients with high-grade glioma: a pilot study. Journal of Neuro-Oncology 97:1, pages 109-115.
Crossref
Sophie D. Fosså, Jan Oldenburg & Alv A. Dahl. (2009) Short‐ and long‐term morbidity after treatment for testicular cancer. BJU International 104:9b, pages 1418-1422.
Crossref
Karin GehringMargriet M. SitskoornChad M. GundySietske A.M. SikkesMartin KleinTjeerd J. PostmaMartin J. van den BentGuus N. BeuteRoelien H. EntingArnoud C. KappelleWillem BoogerdTheo VeningaAlbert TwijnstraDolf H. BoermanMartin J.B. TaphoornNeil K. Aaronson. (2009) Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial. Journal of Clinical Oncology 27:22, pages 3712-3722.
Crossref
ANDERS DEGN PEDERSEN, PHILIP ROSSEN, MIMI YUNG MEHLSEN, CHRISTINA GUNDGAARD PEDERSEN, ROBERT ZACHARIAE & HANS VON DER MAASE. (2009) Long-term cognitive function following chemotherapy in patients with testicular cancer. Journal of the International Neuropsychological Society 15:02, pages 296.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.